Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Deepinder K Dhaliwal, AAO 2020 – Myopia Options in a 50-year-old Myope

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Dec 3rd 2020

We were delighted to speak with Deepinder K Dhaliwal (University of Pittsburgh School of Medicine, Pittsburgh, PA, USA) about her refractive surgery panel at AAO 2020, discussing a case of a 50-year-old -8.00D myope, and the issues and recommendations for treatment.

Questions

  1. Could you give us a brief overview of the case; who were the panelists and was there global representation? (00:08)
  2. What are the issues when dealing with a high myope with a clear lens? (00:35)
  3. What were the recommendations by the panelists? (01:40)
  4. What are the key learning points from this presentation? (03:24)

 

Speaker Disclosure: Dr Deepinder K Dhaliwal has been a consultant for Johnson and Johnson, and a speaker for Staar Surgical.

Support: Interview and filming supported by Touch Medical Media Ltd.

Filmed in coverage of AAO 2020.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup